Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease

[1] Zetterberg H(2017)2017 Alzheimer’s disease facts and figures Alzheimer Dement 13 325-73

[2] Rohrer JD(2017)Cerebrospinal fluid in the dementias Handb Clin Neurol 146 85-97

[3] Schott JM(2011)Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 280-92

[4] Sperling RA(2013)Fluid biomarkers in Alzheimer’s disease – current concepts Mol Neurodegener 8 20-17

[5] Rosén C(2016)Alzheimer’s disease Lancet 388 505-205

[6] Scheltens P(2017)Molecular and cellular aspects of age-related cognitive decline and Alzheimer’s disease Behav Brain Res 322 191-86

[7] Hullinger R(2017)The effects of aging in the hippocampus and cognitive decline Neurosci Biobehav Rev 79 66-901

[8] Puglielli L(2009)CSF biomarker levels in early and late onset Alzheimer’s disease Neurobiol Aging 30 1895-3

[9] Bettio LEB(1993)Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families Science 261 921-7

[10] Rajendran L(2009)Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age Ann Neurol 65 650-33

[1] Zetterberg H(2017)2017 Alzheimer’s disease facts and figures Alzheimer Dement 13 325-73

[2] Rohrer JD(2017)Cerebrospinal fluid in the dementias Handb Clin Neurol 146 85-97

[3] Schott JM(2011)Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 280-92

[4] Sperling RA(2013)Fluid biomarkers in Alzheimer’s disease – current concepts Mol Neurodegener 8 20-17

[5] Rosén C(2016)Alzheimer’s disease Lancet 388 505-205

[6] Scheltens P(2017)Molecular and cellular aspects of age-related cognitive decline and Alzheimer’s disease Behav Brain Res 322 191-86

[7] Hullinger R(2017)The effects of aging in the hippocampus and cognitive decline Neurosci Biobehav Rev 79 66-901

[8] Puglielli L(2009)CSF biomarker levels in early and late onset Alzheimer’s disease Neurobiol Aging 30 1895-3

[9] Bettio LEB(1993)Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families Science 261 921-7

[10] Rajendran L(2009)Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age Ann Neurol 65 650-33